The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


0.5 Mg/Ml Infus/Pdr/Oral Soln

Merck Sharp & Dohme BVEU/1/00/157/59-67

Main Information

Trade NameAZOMYR
Strength0.5 Mg/Ml
Dosage FormInfus/Pdr/Oral Soln
Licence HolderMerck Sharp & Dohme BV
Licence NumberEU/1/00/157/59-67

Group Information

ATC CodeR06AX27 desloratadine


Licence Issued23/04/2007
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing Status


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back